Abstract Non-alcoholic fatty liver disease (NAFLD) is a global public health issue, of which the prevalence is about 25% worldwide
Label precautions include topics such as: Pancreatitis symptoms Gallbladder disease Acute kidney injury, especially when dehydration occurs from severe GI symptoms Hypoglycemia risk when used with certain diabetes medications (varies by regimen) Hypersensitivity reactions Zepbound labeling includes caution related to pulmonary aspiration during general anesthesia or deep sedation
Quick Answer: Polyethylene glycol 3350 (MiraLAX) is generally considered the best first-line laxative for semaglutide-related constipation due to its gentle mechanism, predictable effects, and minimal systemic absorption
Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones
International Journal of Pharmacy and Pharmaceutical Sciences, 5(2), 34-36
not approved by the FDA, EMA or other agencies